carnosine has been researched along with Ischemic Stroke in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abe, K; Bian, Y; Bian, Z; Feng, T; Fukui, Y; Hu, X; Morihara, R; Nakano, Y; Sun, H; Takemoto, M; Yamashita, T; Yu, H; Yunoki, T | 1 |
Ali, A; Bae, ON; Baek, SH; Burrows, D; De Felice, M; Doeppner, TR; Gardner, I; Jain, S; Kim, D; Kim, ES; Kim, M; Majid, A; Redgrave, J | 1 |
Gao, J; Li, G; Lu, X; Wang, L; Wang, Y; Zhang, Y | 1 |
3 other study(ies) available for carnosine and Ischemic Stroke
Article | Year |
---|---|
Neuroprotective effects of carnosine in a mice stroke model concerning oxidative stress and inflammatory response.
Topics: Animals; Carnosine; Infarction, Middle Cerebral Artery; Ischemic Stroke; Mice; Neuroprotective Agents; Oxidative Stress; Stroke | 2023 |
Comparative Cerebroprotective Potential of d- and l-Carnosine Following Ischemic Stroke in Mice.
Topics: Animals; Brain Chemistry; Carnosine; Cells, Cultured; Disease Models, Animal; Humans; Injections, Intravenous; Ischemic Stroke; Male; Mice; Neurons; Neuroprotective Agents; Primary Cell Culture | 2020 |
Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment.
Topics: Biological Transport; Blood-Brain Barrier; Brain; Brain Ischemia; Carnosine; Cell Line; Dexamethasone; Drug Carriers; Drug Delivery Systems; Humans; Ischemic Stroke; Lactic Acid; Magnetic Iron Oxide Nanoparticles; Nanoparticles; Particle Size; Peptides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2021 |